Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Marie Zhu CEO of MabPlex US at MabPlex


Dr. Marie M. Zhu is currently CEO of MabPlex USA, Inc, a part of MabPlex International. Ltd, which offers one-stop CMO service for development and cGMP manufacturing for biologics including monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs) and other recombinant proteins. Prior to joining MabPlex, Marie was Head of Process Sciences & Manufacturing at Agensys Inc, an Affiliate of Astellas Pharma Inc, with a focus on developing and producing biotherapeutics including mAbs and ADCs to treat prostate, bladder, pancreatic, ovarian, and kidney cancers. Marie has over 22 years of biotherapeutic development/manufacturing experience with contributions to numerous successful IND and BLA filings for a wide range of product types including small molecules, Fc fusion proteins, monoclonal mAbs, and ADCs with leading biotech and pharmaceutical companies: Pfizer, Bristol-Myers Squibb, Xencor, and Agensys/Astellas.

Marie received her B.S degree in Chemical Engineering from Tsinghua University, Beijing, China, and a Ph.D degree in Biochemical Engineering from University of Wisconsin-Madison, Wisconsin, USA.